Vaxtex Cotfab Limited — Others, 09-01-2025: Corporate Insolvency Resolution Process

Vaxtex Cotfab Limited has announced a board meeting regarding the voting results from the 11th meeting of the Committee of Creditors (CoC) as part of its Corporate Insolvency Resolution Process (CIRP). The CoC voted overwhelmingly, with a 99.82% approval rate, to extend the CIRP period, reflecting strong creditor support for ongoing restructuring efforts.

This decision is pivotal as it allows Vaxtex to continue its efforts to stabilize operations and navigate through the insolvency process. Investor sentiment may view this positively, as it suggests a commitment to finding viable solutions and enhancing financial health amidst challenges. The outcome represents a cautious yet optimistic direction for the company’s recovery plans.